معرفی
Rasmus Wentzer Licht serves as a Clinical Professor at Aalborg University Hospital within the Clinical Institute of the Faculty of Health Sciences, specializing in Psychiatry. His academic career spans several decades with substantial contributions to psychiatric research, particularly in bipolar disorders and depression treatment.
Dr. Licht's research interests focus primarily on Bipolar Disorder, Depression, and Psychopharmacology, with significant work on lithium treatment and emerging psychedelic therapies. His fingerprint analysis shows 100% expertise in Bipolar Disorder, followed by strong concentrations in Antidepressants (23%), Dementia Praecox (23%), Major Depressive Episode (22%), Placebo effects (21%), Depression (21%), and Lithium treatments (20%).
His recent publications demonstrate a clear trend toward innovative treatment approaches, particularly exploring psychedelic substances like psilocybin for treatment-resistant depression, alongside continued work on bipolar disorder diagnostics and management. The 2025 publication on psilocybin therapy represents cutting-edge research in alternative depression treatments.
Dr. Licht has been actively involved in media discussions about mental health policy and treatment guidelines, including commentary on the balance between psychiatric and somatic healthcare and critiques of excessive treatment guidelines.
He has supervised multiple PhD students and collaborated on significant research projects, including the 2013-2017 study on the Helping Alliance Questionnaire in music therapy for psychiatric patients. His work has generated substantial impact, particularly the research on psilocybin for depression which has been shared across social media platforms and academic networks.
